Urgent

Toxicological cardiac emergencies

Protocol · Toxicology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

The cardiotoxic poisonings seen in the ED — sodium-channel blockers (TCAs, flecainide, diphenhydramine, cocaine), beta-blockers, calcium-channel blockers and cardiac glycosides (digoxin). A normal-looking rhythm does not exclude critically low output — read and repeat the 12-lead.

Assessment

Investigations

  • ECG clues: wide QRS + terminal R in aVR = Na-channel blockade (TCA QRS >100 ms → seizures, >160 ms → VT risk); brady/AV block → BB/CCB/digoxin; hyperglycaemia supports CCB; digoxin → brady/AV block/ectopy, bidirectional VT, hyperkalaemia in acute toxicity
  • VBG + lactate, U&E, Mg, ionised calcium, glucose; digoxin level + K⁺; repeat the ECG serially (sustained-release agents deteriorate late)
  • Early toxicology / poisons-centre advice

Management

  • Na-channel blocker (wide QRS, hypotension) → sodium bicarbonate 1–2 mmol/kg IV boluses, reassess QRS (keep pH ≤7.55, Na ≤155)
  • CCB/BB shock → high-dose insulin euglycaemia therapy (1 unit/kg bolus then 0.5–1 unit/kg/h + dextrose), calcium (CaCl 10% 10–20 mL), glucagon 2–10 mg, vasopressors (noradrenaline/adrenaline), atropine/pacing
  • Digoxin → digoxin-specific Fab for life-threatening arrhythmia/bradycardia or significant hyperkalaemia; torsades → magnesium 2 g IV
  • Refractory local-anaesthetic / lipophilic toxicity → IV lipid emulsion 20%; refractory shock or arrest from a reversible poison → early VA-ECMO

Disposition

ICU for evolving ECG, shock, seizures or ongoing antidotes; a normal initial ECG or an arbitrary 6-hour window does not exclude delayed cardiotoxicity (sustained-release). Involve the poisons centre + toxicology.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.